Volume Spike Investor

Maxygen Inc. (NASDAQ: MAXY) is a small emerging pharma stock company that almost never generates any “active volume surge” characteristics.  This morning the company sold its hemophelia unit for some $90 million and it is now trading below its net cash basis.  Be sure to read out the longer story linked before if you trade [...]